XTL Biopharmaceuticals acquires 85% of Beyond Air's NeuroNOS subsidiary
Go back to XTL Biopharmaceuticals acquires 85% of Beyond Air's NeuroNOS subsidiary| (NASDAQ: XAIR) | Delayed: 3.36 -0.02 (0.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.38 | 52 Week High | $ | |||
| Open | $3.40 | 52 Week Low | $ | |||
| Day High | $3.43 | P/E | N/A | |||
| Day Low | $3.26 | EPS | $ | |||
| Volume | 38,207 | |||||
| XTL BIOPHARM SP ADR (NASDAQ: XTLB) | Delayed: 2.52 -0.01 (0.4%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.53 | 52 Week High | $1.75 | |||
| Open | $2.44 | 52 Week Low | $0.64 | |||
| Day High | $2.56 | P/E | N/A | |||
| Day Low | $2.40 | EPS | $0.00 | |||
| Volume | 5,726 | |||||
